Pharming (PHAR) Stock Price, Quote, News & History | Benzinga

Pharming Group (PHAR) Stock Price, Quote, News & History

PHARNASDAQ

Trade with Public

Trade with Public

$12.65

0.141.12%

At close: Jun 17, 5:00 PM EST

$12.99

0.342.69%

After Hours: Jun 16, 9:30 AM EST

OverviewNews Earnings Events Guidance Analyst Ratings Short Interest Stock Report

Key Statistics

Open

$12.56

Close

$12.65

Volume / Avg.

1.84K / 15.29K

Day Range

$12.56 - $12.97

52 Wk Range

9.54 - 21.34

Market Cap

$917.42M

P/E Ratio

65.84

Dividend Yield

-

Exchange

NASDAQ

RSI

45

Short Interest

0.01%

Days to Cover

1

Recent Pharming Group NV News

FDA Strikes Off European Biotech Pharming's Immune Deficiency Drug For Expanded Use In Pediatric Patients

FDA issued a CRL to Pharming's Joenja child use filing, citing dosing concerns in lower-weight kids and testing issues.

Vandana Singh

European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug

Pharming's Phase 3 trial results for leniolisib in children with APDS demonstrate efficacy and safety, supporting future regulatory filings in 2025.

Vandana Singh

Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

56.43M

Investing Cash Flow (TTM)

-68.20M

Financing Cash Flow (TTM)

-1.01M

Free Cash Flow (TTM)

55.72M

Capital Expenditure (TTM)

-705.00K

Net Change in Cash (TTM)

-12.78M

Analyst Trends and Forecast

2

Mar

1

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$841.93M

PE Ratio (TTM)

65.84

PE Ratio (FWD)

26.04

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.59

PB Ratio (TTM)

3.28

Earnings Yield % (TTM)

1.52%

Earnings Yield % (FWD)

3.84%

EV / EBITDA (TTM)

21.08

Price / EBITDA (TTM)

23.98

Price / Free Cash Flow (TTM)

17.19

Book Value / Share

$3.81

Company Debt

Total Debt

$98.77M

LT Debt

$93.39M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$16.51M

Total Cash

$52.38M

Debt to Equity

0.43

Issuance of Debt (TTM)

-$16.51M

Repayment of Debt (TTM)

-$16.51M

Key Statistics

Open

$12.56

Close

$12.65

Volume / Avg.

1.84K / 15.29K

Day Range

$12.56 - $12.97

52 Wk Range

9.54 - 21.34

Market Cap

$917.42M

P/E Ratio

65.84

Dividend Yield

-

Exchange

NASDAQ

RSI

45

Short Interest

0.01%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabili...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Pharming (PHAR) stock?

A

You can purchase shares of Pharming (NASDAQ:PHAR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Pharming (PHAR) competitors?

A

There are no as such competitors for Pharming.

Q

What is the forecast, or price target, for Pharming (PHAR) stock?

A

Pharming has a consensus price target of $33.60.

Q

What is the current price for Pharming (PHAR)?

A

The stock price for Pharming (NASDAQ: PHAR) is $12.99 last updated June 16, 2026 at 9:30 AM EDT.

Q

Does Pharming (PHAR) pay a dividend?

A

There are no upcoming dividends for Pharming.

Q

When is Pharming (NASDAQ:PHAR) reporting earnings?

A

Pharming does not have any upcoming earnings scheduled.

Q

Is Pharming (PHAR) going to split?

A

There is no upcoming split for Pharming.

Q

What sector and industry does Pharming (PHAR) operate in?

A

Pharming is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.